T-group (topology)
2003.1.8 MurCD/PglD N-terminal domain-like
Ligands and drugs
1,285
Member domains
85
with ligand contacts (≤ 4 Å)
6.6% of members
68
with DrugDomain annotations
5.3% of members
37
with a DrugBank compound
2.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.8 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01673 | UMA | Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine | 9 |
| DB03397 | UD1 | Uridine-Diphosphate-N-Acetylglucosamine | 2 |
| DB02314 | UAG | Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate | 1 |
| DB03103 | TYD | Thymidine-5'- Diphosphate | 1 |
| DB03435 | UDP | Uridine-5'-Diphosphate | 1 |
| DB08105 | LK1 | N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid | 1 |
| DB08106 | LK2 | N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid | 1 |
| DB08107 | LK3 | N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID | 1 |
| DB08108 | LK4 | N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID | 1 |
| DB08112 | LKM | N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 29 |
| UMA | URIDINE-5'-DIPHOSPHATE-N-ACETYLMURAMOYL-L-ALANINE | 12 |
| CAmetal | CALCIUM ION | 3 |
| JB2 | GDP-perosamine | 3 |
| EPU | URIDINE-DIPHOSPHATE-2(N-ACETYLGLUCOSAMINYL) BUTYRIC ACID | 2 |
| EPZ | (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid | 2 |
| PO3 | PHOSPHITE ION | 2 |
| SO3 | SULFITE ION | 2 |
| UD1 | URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE | 2 |
| UD4 | UDP-2-acetamido-4-amino-2,4,6-trideoxy-alpha-D-glucopyranose | 2 |
| 051 | (1R,3R,4S)-4-[({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)AMINO]CYCLOHEXANE-1,3-DICARBOXYLIC ACID | 1 |
| 0FX | dTDP-4-amino-4,6-dideoxyglucose | 1 |
| A1BIH | N~2~-octanoyl-L-lysine | 1 |
| ACO | ACETYL COENZYME *A | 1 |
| D17 | N-({3-[({4-[(Z)-(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl}amino)methyl]phenyl}carbonyl)-L-glutamic acid | 1 |
| IK4 | N-({7-[(4-cyanobenzyl)oxy]naphthalen-2-yl}sulfonyl)-D-glutamic acid | 1 |
| JB3 | GDP-N-acetylperosamine | 1 |
| JBT | GDP-N-acetylperosamine-coenzyme A | 1 |
| LK1 | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-L-GLUTAMIC ACID | 1 |
| LK2 | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-D-GLUTAMIC ACID | 1 |